Resistant and relapsing neuroblastoma: Improved response rate with a new multiagent regimen (OC‐HDP) including high‐dose cisplatinum

Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer a southwest oncology group study

1984 • 188 citations

Recent advances in bone marrow transplantation

1983 • 178 citations

Alterations in the toxicity of cis-Dichlorodiammineplatinum-II and in tissue localization of platinum as a function of NaCl concentration in the vehicle of administration

1981 • 170 citations

Advanced neuroblastoma: improved response rate using a multiagent regimen (OPEC) including sequential cisplatin and VM-26.

1984 • 154 citations

High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma

1982 • 152 citations

Neuroblastoma: Review of the literature and an examination of factors contributing to its enigmatic character

1976 • 150 citations

Treatment of poor prognosis nonseminomatous testicular cancer with a “high-dose” platinum combination chemotherapy regimen

1983 • 146 citations

USE OF PANELS OF MONOCLONAL ANTIBODIES IN THE DIFFERENTIAL DIAGNOSIS OF NEUROBLASTOMA AND LYMPHOBLASTIC DISORDERS

1983 • 131 citations

Clinical evaluation of sequentially scheduled cisplatin and vm26 in neuroblastoma: Response and toxicity

1981 • 99 citations

AN EXPERIMENTAL BIOLOGICAL BASIS FOR INCREASING THE THERAPEUTIC INDEX OF CLINICAL CANCER THERAPY

1982 • 30 citations